Why Grey-Market Businesses Need Different Tax Planning

As most of our audience understands, Calyx specializes in the plant medicine industries, specifically cannabis and psychedelics. However, we are frequently approached by fringe health and wellness companies that sell products labeled "research only" or "not for human consumption," or that include disclosures that the products are "not FDA approved for mental health purposes," while still being purchased by customers hoping to enhance their physical or mental wellbeing.

The risk is not always that these businesses are pushing legal boundaries. The risk is uncertainty: they often depend on legal classifications that are narrow, technical, unsettled, or subject to change.

That is the tax problem hidden inside many grey-market businesses. The revenue may be real. The customers may be real. The operators may be serious, experienced, and compliant within the policies available to them. But the business may still be relying on a much narrower legal position than regulators may ultimately accept.

Where the Grey-Market Risk Comes From

This is especially true for cannabis and adjacent regulated-substance, plant-medicine, controlled-clinic, retail wellness-compound, and performance-enhancement businesses. These companies often operate where state licensing, DEA or FDA regulation, medical practice rules, pharmacy rules, advertising claims, banking access, insurance underwriting, and tax law do not line up neatly.

A company may be licensed by a state but restricted under federal law. A product may be widely sold online but not lawfully marketed as a food, dietary supplement, or drug. Legal prescription does not automatically make the business legally compliant. A compound may be marketed as hemp, plant medicine, functional mushrooms, research use only, wellness, anti-aging, or performance-enhancing, while regulators may view the same product or business model very differently.

Cannabis and intoxicating hemp businesses are the clearest example. These companies may operate under state licensing rules or federal hemp definitions, yet still face federal controlled-substance issues, FDA concerns, banking restrictions, insurance limitations, and unusual tax consequences. The market may treat the product as normalized, but the tax and regulatory systems often do not.

Psychedelic and psychedelic-adjacent businesses face a different version of the same problem. Some operate under state-regulated programs, some under religious-use, and others through retreats, clinics, integration services, or wellness branding. Even when the business is serious and professionally run, the legal position may be flimsy, or a theory that federal authorities have not fully embraced.

Controlled-clinic and wellness-treatment businesses, such as ketamine, hormone, peptide, anti-aging, or performance-enhancement practices, may involve substances that can be lawfully prescribed or administered in certain settings. But legal prescription does not automatically make the business legally secure. Questions can still be raised about off-label use, improper compounding, telehealth without proper supervision, advertising, ownership, and whether medical judgment is separated from business control.

Retail wellness-compound businesses, including products marketed as kratom, functional mushrooms, nootropics, research compounds, or "not for human consumption," often create risk because the product may be widely available before its legal status is settled. The issue is not always whether customers can buy it. The issue is whether the product can lawfully be labeled, marketed, consumed, shipped, or sold through the channel the business is using.

Entity Choice Becomes a Risk-Containment Question

In ordinary businesses, choosing between an LLC, S corporation, partnership, or C corporation is often framed as a tax-efficiency decision. In grey-market businesses, however, entity choice is more about containment of liability. The question is not only how the business should be taxed if everything goes well. The harder question is who bears the tax consequences if the rules change, the IRS audits, or the business has to shut down.

Why C Corporations Often Fit Grey-Market Risk Better

At Calyx, our preferred tax structure for businesses like these is often C corporation treatment.

That does not mean it is a mistake to form an LLC. An LLC is familiar, inexpensive, flexible, and can elect to be taxed as a C corporation. The mistake is allowing a grey-market business to default into pass-through taxation without understanding what can pass through to the owners personally.

A pass-through entity can push taxable income and audit adjustments directly to the owners. That may be manageable in a stable business with predictable profits and regular distributions. It is less attractive when the company operates in a market where deductions can be challenged, the legal position can change in an instant, and operations might immediately stop for a number of reasons.

A C corporation pays its own federal income tax. Its income does not pass through to shareholders each year. That characteristic can be especially valuable when the business itself is the risk container. The corporation operates the business, faces the regulatory exposure, and bears the business-level tax result.

This matters most when things go badly. If a grey-market company generates taxable income on paper but spends the cash operating the business, pass-through owners may be personally taxed on income they never actually received. If the company later shuts down, the tax problem may remain with the owners. In a C corporation, the tax liability is generally contained inside the corporation.

C corporations also fit the way many high-risk ventures are financed. Sophisticated entrepreneurs and investors understand containing risk. They do not just look for the lowest possible tax outcome. They are prepared if the venture fails.

That does not mean a C corporation is magic. It does not make an unlawful product lawful. It does not cure weak contracts, poor books, aggressive marketing claims, bad payroll practices, or regulatory noncompliance. It can also create double-tax issues and requires discipline around compensation, distributions, state taxes, capitalization, and exit planning.

The Main Point

Grey-market businesses need to be structured for volatility, not just for success.

The central question is not whether the business is exciting, fast-growing, or technically allowed to operate today. The central question is what legal position the business is relying on, how stable that position is, and who bears the tax consequences if it is challenged.

For ordinary businesses, entity choice is often about efficiency. For grey-market businesses, entity choice is about containment. That is why C corporation treatment is often the better starting point. It helps keep business tax risk inside the business, where it belongs, rather than allowing a narrow or unstable legal position to become a personal tax problem for the owners.

A well-structured C corporation will not eliminate regulatory exposure. But combined with disciplined accounting, clean categorization, and documentation, it can give founders, investors, and advisors a stronger structure for operating in markets where the law has not caught up with commercial reality.